2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-(3,4'-bipyridin)-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-1(6H)-one,
GDC-0853,
Fenebrutinib,
GDC-0853,
1434048-34-6,
GDC0853,
UNII-E9L2885WUL,
E9L2885WUL,
RG7845,
(S)-2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4'-bipyridin]-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one,
2-[3'-(hydroxymethyl)-1-methyl-5-({5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl}amino)-6-oxo[1,6-dihydro[3,4'-bipyridine]]-2'-yl]-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one,
Fenebrutinib [INN],
Fenebrutinib [USAN],
GTPL9299,
CHEMBL4065122,
SCHEMBL14912882,
BCP19175,
EX-A1308,
GDC 0853,
AKOS032945119,
ZINC220197997,
CS-5927,
GDC-0853(RG7845),
RG-7845,
HY-19834,
Example 130 [US20140194408],
RO7010939,
J3.615.209E,
A16339,
G02599853,
2H-Cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-1(6H)-one, 2-(1,6-dihydro-3'-(hydroxymethyl)-1-methyl-5-((5-((2S)-2-methyl-4-(3-oxetanyl)-1-piperazinyl)-2-pyridinyl)amino)-6-oxo(3,4'-bipyridin)-2'-yl)3,4,7,8-tetrahydro-7,7-dimethyl-,
9AJ,